Product release is rate-limiting for catalytic processing by the Dengue virus protease

Dengue Virus (DENV) is the most prevalent global arbovirus, yet despite an increasing burden to health care there are currently no therapeutics available to treat infection. A potential target for antiviral drugs is the two-component viral protease NS2B-NS3pro, which is essential for viral replicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Shannon, A. E., Pedroso, M. M., Chappell, K. J., Watterson, D., Liebscher, S., Kok, W. M., Fairlie, D. P., Schenk, G., Young, P. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126634/
https://www.ncbi.nlm.nih.gov/pubmed/27897196
http://dx.doi.org/10.1038/srep37539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126634/
https://www.ncbi.nlm.nih.gov/pubmed/27897196
http://dx.doi.org/10.1038/srep37539

Ejemplares similares